Advanced Solid Tumors: STP938 Treatment Study

We are testing a new drug called STP938 in adults with advanced solid tumors, including those with a specific type of ovarian cancer. The study aims to evaluate the safety of this treatment.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Antoine Lacassagne
Service d’oncologie
Nice, France
Centre De Lutte Contre Le Cancer Eugene Marquis
Service de Gynécologie oncologie
Rennes, France
Institut Gustave Roussy
DITEP (Département d’Innovation Thérapeutique et d’Essais Précoces)
Villejuif, France

Sponsor: Step Pharma
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.